TOP
Nav Bar
  1. General Info
  2. Effects Info
  3. Reference
Drug Interaction Details
01. General Information
Pair Name Ursolic acid, Epirubicin
Phytochemical Name Ursolic acid (PubChem CID: 64945 )
Anticancer drug Name Epirubicin (PubChem CID: 41867 )
Structure of
Phytochemical
2D-img
Download
2D MOL 3D MOL
Structure of
Anticancer Drug
2D-img
Download
2D MOL 3D MOL
02. Combinatorial Therapeutic Effect(s)
Synergistic Effect
Hide/Show
Enhancing Drug Efficacy
Hide/Show
Combination Pair ID: 190
Pair Name Ursolic acid, Epirubicin
Disease Info [ICD-11: 2C60] Breast cancer Investigative
Biological Phenomena Induction-->Autophagy
Gene Regulation Down-regulation Expression AKT1 hsa207
Up-regulation Expression ATG5 hsa9474
Up-regulation Expression ATG7 hsa10533
Up-regulation Expression BECN1 hsa8678
Up-regulation Expression MAP1LC3A hsa84557
Up-regulation Expression MAP1LC3B hsa81631
Down-regulation Expression PIK3CA hsa5290
In Vitro Model MDA-MB-231 Breast adenocarcinoma Homo sapiens (Human) CVCL_0062
MCF-7 Invasive breast carcinoma of no special type Homo sapiens (Human) CVCL_0031
Result These findings indicate that UA can dramatically enhance the sensitivity of MCF-7 and MDA-MB-231 cells to EPI by modulating the autophagy pathway. Our study may provide a new therapeutic strategy for combination therapy.
03. Reference
No. Title Href
1 Ursolic Acid Enhances the Sensitivity of MCF-7 and MDA-MB-231 Cells to Epirubicin by Modulating the Autophagy Pathway. Molecules. 2022 May 25;27(11):3399. doi: 10.3390/molecules27113399. Click
It has been 64936 visits since 2024.08
If you find any error in data or bug in web service, please kindly report it to Dr. Zhang
TOP